Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 19 March 2020. Phil Roe.

Executive Summary

The US government will study ways to reduce American manufacturers’ dependence on a foreign supply chains for devices and drugs under a bill introduced on 12 March by Sens. Lamar Alexander and Dick Durbin. Here’s what Rep. Phil Roe, R-TN, said about related House legislation.

“While the US took significant steps in preparing to address COVID-19, unfortunately we are learning how reliant we are on China for the production of gowns, masks and components for manufacturing drugs.” – US Rep. Phil Roe, R-TN

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel